Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.35 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3214629 | 0.84 | NPC1 (0.42) | DNM1KCNH2PLA2G2ABLMRXRA | |
| SCHEMBL1459455 | 0.84 | EGFR (0.44) | DNM1CYP3A4 | |
| SCHEMBL31108460 | 0.83 | PTGS2 (0.57) | PTGS2CYP3A4GPR84 | |
| SCHEMBL21519517 | 0.83 | DNM1 (0.38) | DNM1KCNH2PTGS2CYP3A4PLA2G2A | |
| SCHEMBL10598696 | 0.82 | PLA2G2A (0.42) | PLA2G2ABLMRXRARXRBRXRG | |
| SCHEMBL2399564 | 0.82 | ALDH3A1 (0.40) | DNM1KCNH2ARPLA2G2ABLM | |
| SCHEMBL12677177 | 0.82 | CNR2 (0.46) | DNM1KCNH2 | |
| SCHEMBL1815516 | 0.82 | CNR2 (0.46) | DNM1KCNH2 | |
| SCHEMBL3438591 | 0.81 | AR (0.38) | ARCYP3A4PLA2G2ABLMSLC16A3 | |
| SCHEMBL4447508 | 0.80 | EGFR (0.42) | DNM1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8029920-B2 | 1,3,5-tris(diarylamino)benzenes and use thereof | BANDO CHEMICAL INDUSTRIES, LTD (JP) | 2011-10-04 | — | — | US | claimed |
| EP-1995235-B1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL IND (JP) | 2011-09-14 | — | — | EP | claimed |
| US-20110186834-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-04 | — | — | US | claimed |
| EP-2341043-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF | Bando Chemical Industries, Ltd. (JP) | 2011-07-06 | — | — | EP | claimed |
| US-20090058287-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-05 | — | — | US | claimed |
| EP-1995235-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2008-11-26 | — | — | EP | claimed |
| EP-1696709-B1 | ORGANO-ELECTRONIC FUNCTIONAL MATERIAL AND USE THEREOF | NIPPON STEEL CHEMICAL CO (JP) | 2012-10-24 | — | — | EP | disclosed |
| CN-101395125-B | Novel 1,3,5-tris(diarylamino)benzenes and use thereof | BANDO CHEMICAL IND | 2012-06-13 | — | — | CN | disclosed |
| CN-101395125-B | Novel 1,3,5-tris(diarylamino)benzenes and use thereof | BANDO CHEMICAL IND | 2012-06-13 | — | — | CN | disclosed |
| US-8029920-B2 | 1,3,5-tris(diarylamino)benzenes and use thereof | BANDO CHEMICAL INDUSTRIES, LTD (JP) | 2011-10-04 | — | — | US | disclosed |
| US-8029920-B2 | 1,3,5-tris(diarylamino)benzenes and use thereof | BANDO CHEMICAL INDUSTRIES, LTD (JP) | 2011-10-04 | — | — | US | disclosed |
| US-8029920-B2 | 1,3,5-tris(diarylamino)benzenes and use thereof | BANDO CHEMICAL INDUSTRIES, LTD (JP) | 2011-10-04 | — | — | US | disclosed |
| EP-1995235-B1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL IND (JP) | 2011-09-14 | — | — | EP | disclosed |
| CN-101395125-A | Novel 1,3,5-tris(diarylamino)benzenes and use thereof | BANDO CHEMICAL IND (JP) | 2009-03-25 | — | — | CN | disclosed |
| US-20090058287-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090058287-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-1995235-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2008-11-26 | — | — | EP | disclosed |
| EP-1995235-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2008-11-26 | — | — | EP | disclosed |
| JP-2007246399-A | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND THEIR USE | BANDO CHEM IND LTD | 2007-09-27 | — | — | JP | disclosed |
| WO-2007105783-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110186834-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF | CBR1, CYP1B1, CBR3 | DNM1 2877/4885KCNH2 75/4885AR 1531/4885 |
| US-20090058287-A1 | NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF | TMBIM6, TNPO1, CACNA1I | DNM1 2044/4885KCNH2 81/4885AR 2736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.